We work closely with a select group of clinic-ready start-up businesses to mentor and resource their journey through the clinic, as well as providing tailored, cost-effective clinical development solutions for established businesses. We give our clients unparalleled access to our priority patient populations via our premium clinical execution partners.
| Website | https://www.vxpharma.com |
| Revenue | $1 million |
| Employees | 3 (3 on RocketReach) |
| Founded | 2009 |
| Phone | +27 12 844 0144 |
| Technologies |
JavaScript
,
HTML
,
PHP
+9 more
(view full list)
|
| Industry | Business Consulting and Services, Manufacturing General, Manufacturing |
| Keywords | Pharmaceutical Development, Clinical Research, Drug Development, Clinical Trials, Biopharmaceutical Services, Regulatory Affairs, Drug Manufacturing, Pharmaceutical Consulting, Clinical Trial Management, Medical Research, Healthcare Solutions, Life Sciences, Pharmaceutical Outsourcing, Contract Research Organization, Clinical Operations, Drug Discovery, Biotechnology, Pharmaceutical, Healthcare, Clinical |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck AH, AbbVie, Pfizer, Sanofi, AstraZeneca, Bristol Myers Squibb, Gilead Sciences +45 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Vx Pharma employee's phone or email?
Vx Pharma Questions
The Vx Pharma annual revenue was $1 million in 2026.
Mark Fyvie is the Co-Founder and Director of Vx Pharma.
3 people are employed at Vx Pharma.
Vx Pharma is based in Oxford, England.
The NAICS codes for Vx Pharma are [32, 325, 32541, 3254].
The SIC codes for Vx Pharma are [28, 283].
Top Vx Pharma Employees
-
Mark Fyvie
Co-Founder and Director at Vx Pharma
Cary, NC, US24 -
Coert Cpi
Chief Medical Officer at Vx Pharma
Johannesburg, Gauteng, South Africa
Related Companies
